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Abstract
Both sprint interval training (SIT) and high-intensity intermittent training (HIIT) have been described as time-efficient
strategies for inducing favourable metabolic and cardiorespiratory adaptations in healthy and diseased participants.
Background: To date, little attention has been given to profiling the potential health benefits of HIIT or modified HIIT
training within overweight and obese cohorts with particular focus on inflammation. Within this pilot trial, we tested the
hypothesis that 6 sessions of HIIT performed over 2 weeks with 1–2 days’ rest would improve aerobic capacity, glucose
metabolism and inflammatory profile in an overweight and obese male cohort. Additionally, we profiled the potential
health benefits of 4 HIIT sessions performed over the same period.
Methods: 18 overweight or obese males (BMI = 31.2 ± 3.6; V̇O2 = 30.3 ± 4.4 ml.kg.min
-1) were studied before and 72 h
after HIIT. Training sessions consisted of 10 x 1 min intervals at 90% HRpeak separated by 1 min recovery periods.
Exercise was performed either 6 (group 1, n = 8) or 4 (group 2, n = 10) times over a 2 week period.
Results: After training no changes were detected from baseline for body composition, aerobic capacity, glucose
metabolism or inflammatory profile (p > 0.05) in either group.
Conclusion: Both 6 and 4 sessions of HIIT performed over a 2-week period are ineffective in improving selected health
markers within an overweight and obese cohort.
Trial registration: This trial reports data from human participants and was retrospectively registered on 22/02/2017
with the ISRCTN registry, trial number ISRCTN90672085.
Keywords: High-intensity intermittent training (HIIT), Exercise, Health, Obesity, Inflammation, Prevention
Background
In overweight and obese individuals the core defect under-
lying the development of type 2 diabetes mellitus (T2DM)
is skeletal muscle insulin resistance [1]. Mechanisms and
primary contributing factors of insulin resistance are com-
plex although evidence suggests that physical inactivity
may be the principal initiating factor [2]. Inactivity leads
to reduced energy expenditure, which when combined
with increased energy intake promotes adipose tissue
expansion and with it the development of obesity and a
state of chronic inflammation [3]. Inflammation has been
independently implicated in the development of insulin
resistance and T2DM and is characterised by abnormal
cytokine production, increased production of acute phase
reactants as well as activation of a network of inflamma-
tory signalling pathways [4, 5]. Regular exercise improves
insulin sensitivity and is effective in preventing T2DM [6].
Traditionally, health-oriented physical activity guidelines
have centred on moderate-intensity, continuous forms of
exercise on most days of the week [7]. Although there are
many perceived barriers to performing regular physical
activity [8] one of the most commonly cited obstacles is
lack of time [9] and when combined with recent evidence
suggesting that some individuals prefer an intermittent
exercise protocol in comparison to continuous exercise
[10], it may be timely to consider novel forms of exercise
that may be more readily adopted.
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Previous work suggests that sprint interval training (SIT)
in healthy populations provides a time-efficient strategy for
inducing metabolic and cardiorespiratory adaptations com-
parable to those seen following traditional endurance based
training [11–17]. Furthermore several authors have dem-
onstrated that SIT and high-intensity interval training
(HIIT), a moderately less intensive exercise modality, may
have favourable effects on metabolic control after as few as
6 sessions in healthy [13, 14, 18–23], obese [24, 25], meta-
bolic disease [26, 27], and heart failure participants [28].
Although positive effects have been previously demon-
strated, it should be made clear that few trials cited here
[11, 14] have utilised a short 2 week training period, in-
stead longer durations have been employed which could
have been responsible for health improvements.
Sprint interval training may be physically overreaching
for sedentary and/or obese populations to complete effi-
ciently. Recent modification of classic SIT exercise has
led to more manageable HIIT training, which has shown
to be metabolically effective. Little and colleagues [27]
employed a manageable 2 week HIIT intervention within
a T2DM cohort. Participants completed HIIT 3 x per
week with exercise consisting of 10 x 1 min bicycle in-
tervals at 90% of participants’ maximum heart rate
(HRmax) whilst maintaining 80–100 RPM. Results dem-
onstrated that with just a 75 min weekly training com-
mitment key markers of glucose control were all
significantly improved. Furthermore, the maximal work-
load achieved during a maximal cycling test increased by
10%. These data demonstrated that low-volume HIIT re-
duced hyperglycaemia and improved glucose tolerance
whilst being well tolerated by a clinical population.
Exercise prescription is an important adjunct to clin-
ical management in the prevention of cardio-metabolic
disease [29]. While the traditional approach of prescrib-
ing moderate-intensity continuous exercise has been
associated with improved health outcomes and a low in-
cidence of adverse events [30], there is growing evidence
for a dose–response relationship between exercise inten-
sity and all-cause mortality, suggesting that higher-
intensity exercise may afford greater benefit [31]. As
such, we aimed to profile the aforementioned [27] HIIT
intervention to assess if positive health improvements
would be achieved in an overweight and obese cohort
who may be at risk of developing cardio-metabolic
disease. Specifically we aimed to look in detail at a broad
spectrum of risk factors, including inflammatory
markers that have, to date, received little attention in
this specific context.
Furthermore, an early meta-analysis [32] indicated that
with exercise intensities ~90% of maximum oxygen up-
take (V̇O2max) with relatively short total exercise dur-
ation, 2 sessions per week could produce increases in
V̇O2max in individuals with low initial fitness levels. It is
yet to be elucidated if this is true following HIIT within
an overweight and obese cohort and if improvements
can be seen in parameters other than V̇O2max. We there-
fore sought to evaluate a modified version of the above
protocol with reduced weekly exercise volume.
Methods
Experimental Approach to Problem
Given the prominent exercise barrier of ‘time commit-
ment’ we endeavoured to profile physiological changes
associated with a reduced frequency variation of the
aforementioned exercise protocol [27]. We hypothesised
that previous findings will be replicated when conducted
in an overweight and obese cohort, with glucose, insulin
and inflammatory profiles expected to improve. Add-
itionally, we expected to see improvements in V̇O2peak
following 4 exercise sessions in a 2-week period. For a
experimental protocol please see Fig. 1.
Participants
Full participant characteristics are provided in Table 1.
Participants’ eligibility to take part in this study was de-
termined during a pre-assessment session with a mem-
ber of the research team. Herein, participants completed
questionnaires assessing health status and physical activ-
ity habits. Blood pressure, BMI and fasting blood glucose
Fig. 1 Schematic illustrating the experimental protocol. Visits 1, 2 and 3 took place before commencement of the HIIT. Visits 4-9 were spread over
2 weeks of training (i.e., 2 or 3 HIIT sessions per week with 24 - 72h between each session). Visits 10 took place 48 h after the last training session
and visit 11 took place 72h after the last training session
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(finger prick) were also assessed using a point-of-care
analyser. All participants had a BMI ≥ 27 kg · m-2,
reported taking part in any form of exercise less than 2
times per week, but were otherwise healthy. Participants
were excluded if they were smokers, were diagnosed
with impaired fasting glucose or diabetes, or had a
BMI ≥ 40 kg.m-2.
Procedures
Blood Pressure
Arterial blood pressure was measured using a digital
automatic blood pressure monitor (Omron M7, Omron
Healthcare UK Ltd, Milton Keynes, UK). Participants
remained in a supine position for 10 min before the 1st
measurement. A cuff was placed around the upper dom-
inant arm with participants’ arm rested on a firm surface
during all measurements. Blood pressure was measured
3 times and the reported results are an average of the 3
readings.
Body Composition
Body mass (kg) was determined using a balanced beam
scale (Seca, Hamburg, Germany) with height (cm) mea-
sured using an attached stadiometer (Seca, Hamburg,
Germany) with participants wearing only shorts and no
footwear. Participants had waist and hip circumferences
measured with a measuring tape. Waist circumference
was measured halfway between the iliac crest and the
lowest rib. Hip circumference was measured at the wid-
est part of the hips. These measurements were used to cal-
culate the waist-hip ratio. Actual circumferences were
determined from the average of two assessments at each
site were both measurements being repeated in instances
where measurements were more than 1 cm apart.
Total body composition was measured by dual-energy
X-ray absorptiometry (DEXA) on a Lunar Prodigy (GE
corporation, Connecticut, USA) which segmented the
body into 3 compartments of fat mass, bone mineral
content and fat-free soft tissue, the last 2 of which con-
stitute fat-free mass and percent body fat. DEXA has
been validated as a measure of body fat in overweight
and normal weight individuals [33–35].
Oral Glucose Tolerance Test
Participants attended the laboratory having fasted for at
least 12 h overnight. Plasma insulin and glucose were
determined from venous blood samples collected from a
21 gauge cannula inserted into an antecubital vein.
Blood samples were collected before, 30 min, 60 min,
90 min and 120 min after ingestion of 82.5 g dextrose
monohydrate dissolved in 200 ml of water. This solution
was immediately washed down with 100 ml of water.
The cannula was kept patent via regular flushing with
0.9% (w/v) saline solution. The first 2 ml of blood ex-
tracted from the cannula via a syringe was discarded.
Blood samples were collected into vacutainers (Becton
Dickinson, Plymouth, UK) containing either 1.8 mg ethyl-
enediaminetetraacetic acid (EDTA) per ml of blood (glu-
cose and inflammatory hormones) or 17 IU lithium
heparin per ml of blood (insulin). Blood samples were
gently inverted 8 times and then placed on an SRT6 roller
mixer (Bibby Scientific Ltd, Stone, UK) to ensure mixing.
Insulin and inflammatory blood samples were immedi-
ately centrifuged at 3500 g (10 min at 4 oC) (Heraeus
Labofuge 400 R, Langenselbold, Germany) and the
plasma aliquoted into labelled eppendorf tubes and
stored at -80oC until analysis. Whole blood glucose was
analysed immediately using a glucose oxidase reaction
via an automated analyser (YSI Stat 2300, Yellow Spring
Instruments, Ohio, USA). The area under the curve
(AUC) for plasma insulin and glucose were calculated
from baseline (0 min) to 120 min after ingestion of the
Table 1 Body composition, blood pressure and peak oxygen uptake for groups 1 and 2 pre and post 2 weeks of HIIT
Group 1 (6 HIIT sessions) Group 2 (4 HIIT sessions)
Pre-Training Post-Training p Pre-Training Post-Training p
Mean (SD) Mean (SD) Sig. < 0.05 Mean (SD) Mean (SD) Sig. < 0.05
Body Mass (kg) 94.5 (13.9) 94.4 (14.3) 0.798 104.8 (17.6) 104.6 (17.0) 0.524
BMI (kg.m2) 29.7 (3.4) 29.7 (3.5) 0.716 32.3 (3.3) 32.3 (3.2) 0.557
Waist Circumference (cm) 100.4 (9.1) 99.1 (9.2) 0.164 109.6 (10.4) 108.6 (10.4) 0.316
Hip Circumference (cm) 107.6 (6.5) 106.9 (6.4) 0.235 113.9 (7.3) 112.7 (9.4) 0.499
Waist-to-hip ratio 0.9 (0.03) 0.9 (0.03) 0.709 1.0 (0.05) 1.0 (0.03) 0.879
Systolic BP (mmHg) 131.1 (15.8) 124.6 (10.5) 0.446 122.8 (8.2) 124.7 (5.2) 0.348
Diastolic BP (mmHg) 84.7 (10.9) 76.0 (9.7) 0.185 76.8 (7.1) 75.8 (5.4) 0.829
V̇O2peak (l.min
-1) 3.3 (0.7) 3.7 (0.8) 0.138 3.2 (0.5) 3.2 (0.4) 0.846
V̇O2peak (ml.kg
-1.min-1) 35.6 (5.4) 38.5 (5.4) 0.135 30.4 (4.2) 30.5 (3.9) 0.960
BMI body mass index; BP blood pressure
Group 1 (N = 8); Group 2 (N = 10)
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dextrose drink using the trapezoidal method. Tests were
performed approximately 1 week prior to and exactly
72 h post exercise intervention.
Maximal Oxygen Uptake
V̇O2peak was determined using a continuous incremental
exercise test on an electromagnetically braked cycle erg-
ometer (Lode Excalibur, Groningen, The Netherlands),
performed to volitional exhaustion. Expired air was mea-
sured continuously using an online breath-by-breath gas
analysis system (Cortex Metalyzer, CPX International
Inc., Berlin, Germany). Participants warmed up for
5 min against a resistance of 50 W, after which the
workload was increased linearly by 16 W per minute
until the participant could no longer maintain 50 RPM.
V̇O2peak was identified as the highest value achieved over
15 breaths, taken from a rolling average. HR was mea-
sured throughout the test using a telemetric heart rate
monitor, which was wirelessly paired with the breath-by-
breath analysis system (Polar RS100, Polar Electro UK
Ltd, Warwick, England).
High Intensity Interval Training
The HIIT protocol utilised in this study was based on
that devised by Little and colleagues [27]. Participants
warmed up at a resistance of 50 W for 3 min and during
the last 10 s participants counted down before the watt-
age was elevated to a pre-determined resistance set to
elicit 90% HRpeak. Resistance was manipulated manually
throughout to ensure pre-determined heart rate values
were achieved. During the 60 s high intensity interval, par-
ticipants were asked to maintain a cadence of 80–100
RPM. After 60 s of high intensity cycling participants were
instructed to cycle for the next 60 s at a cadence of 70–80
RPM against a resistance of 50 W (active recovery). This
was repeated a further 9 times followed immediately by a
2 min cool down against a resistance of 50 W.
Group 1 (N = 8) completed 6 sessions of HIIT exercise
over a 2-week period where as group 2 (N = 10) com-
pleted only 4 over the same period. Group 1 exercise
sessions were carried out on Mondays, Wednesdays, and
Fridays. Group 2 sessions were conducted on Mondays
and Fridays.
ELISAs and Biochemical Analysis
Adiponectin, MCP-1, IL-10, CRP and TNF-α were quan-
tified using commercial sandwich enzyme linked im-
munosorbent assays (ELISAs) and TNF-α and IL-10
were measured via high sensitivity ELISAs (R & D sys-
tems, Minneapolis, MN, USA).
Plasma IL-6 and sIL-6R were analysed via ‘in-house’
ELISAs as detailed elsewhere [37, 38]. Materials and
chemical reagents were obtained from Sigma-Aldrich Ltd
(Poole, UK) unless otherwise specified. All incubation
periods were at room temperature and during each incu-
bation stage the plate was placed on a Stuart Mini Orbital
Shaker (Bibby Scientifc Ltd, Stone, UK) at 60 revs.min-1
unless otherwise stated. Wash steps for ELISAs were
carried out manually using an 8 way multi-channel
pipette (BioHIIT eLINE, Helsinki, Finalnd). The absorb-
ance of wells was read using a Varioskan Flash Mutimode
Reader (Thermo Scientific, Vantaa, Finland). Protein
concentration of samples was determined in relation to a
4-parameter logistic standard curve. All samples were ana-
lysed in duplicate and were repeated if the coefficient of
variation (CV) between duplicates was more than 10%.
The intra-assay CVs for the inflammatory proteins were as
follows: adiponectin (3.5%), IL-10 (8.7%), TNF-α (7.8%),
CRP (5.3%), IL-6 (4.8%), sIL6-R (3.5%), MCP-1 (6.4%).
Insulin Sensitivity Index
Insulin sensitivity was estimated using the Matsuda
index of insulin sensitivity [36] which is a validated
measure which correlates highly (r = 0.73) with the rate
of whole body glucose disposal during a euglycaemic-
hyperinsulinaemic clamp.
Statistical analysis
Statistical analysis was carried out using SPSS version 19
(SPSS Inc, an IBM company). All variables were checked
for distribution with a Shapiro-Wilk test confirming normal
distribution throughout. Statistical significance was as-
sumed at p < 0.05. The primary outcome measure was the
change in fasting glucose from pre- to post-intervention,
with a clinically relevant difference between the interven-
tions of 15%. Based on data on repeated measures of the
oral glucose tolerance test (OGTT) test protocol, it is calcu-
lated that with a power of 80% and alpha set at 0.05, 8 par-
ticipants are required per group to detect the minimal
clinically relevant difference between the two interventions.
Pre to post-training differences in basal plasma glucose,
insulin, glucose and insulin AUC, anthropometry and
V̇O2peak data were assessed using paired sample t-tests.
Additionally, group differences were assessed via compari-
son of delta change using independent t-test. This approach
was favoured over ANOVA due to the small sample size
and because each group was to be evaluated for independ-
ent efficacy and not as a comparison between groups.
Results
Body composition, blood pressure and peak oxygen uptake
There were no differences in characteristics between
groups at baseline (Table 1). Following 6 sessions of
HIIT over 2 weeks (Group 1), there were no changes in
body mass, waist and hip circumferences or BMI
(p > 0.05). Additionally no significant changes in V̇O2peak
were observed following HIIT in group 1, in absolute or
relative terms. Figure 2 details individual changes in
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V̇O2peak from baseline. These findings were replicated in
group 2 who completed 4 sessions of HIIT over 2 weeks
(Table 1).
On assessment of DEXA data no changes in tissue and
regional fat (%), total tissue (g), total lean tissue (g), total
fat tissue (g) or bone mineral content (BMC) (g) were ob-
served within or between groups (p > 0.05) (Figs. 3 and 4).
Inflammatory proteins in the circulation at rest
After training there were no changes in plasma adipo-
nectin, IL-10, TNF-α, IL-6, sIL-6R, CRP, or MCP-1
(p > 0.05) for either group (Table 2).
Insulin sensitivity
There were no significant changes in fasting glucose
(Fig. 5), insulin or the insulin sensitivity index (Fig. 6) nor
were there any differences found for the area under the
curve in response to a 75 g OGTT in any group. The glu-
cose and insulin responses to the 2 h OGTT before and
after training is shown in Fig. 7a and b. Individual
responses in insulin resistance are shown in Fig. 5.
Discussion
The primary aim of this study was to profile the effect-
iveness of a previously described HIIT protocol [27],
for improving aerobic capacity, glucose control and in-
flammatory profile in an overweight and obese cohort.
Secondary to this we endeavoured to assess how the re-
sponse differed when the protocol volume was reduced.
This study has demonstrated that 3 sessions of submaxi-
mal high-intensity exercise per week is not sufficient for
improving any of the aforementioned parameters in our
overweight and obese cohort; this is also true following 2
sessions of HIIT per week over a 2 week period.
Inflammation
Exercise of varying intensities may improve wellbeing and
combat some of the basal increase in inflammation often
associated with obesity, T2DM and cardiovascular disease
[39–43]. The present investigation failed to identify any
measurable changes in circulatory inflammatory proteins
at rest following 2 weeks of HIIT in group 1 or group 2.
Data detailing the effects of SIT or HIIT on inflam-
matory status in an overweight or obese cohort is min-
imal. In a study that used a running mouse model,
high-intensity training was associated with reduced
pro-inflammatory and increased anti-inflammatory cyto-
kine expression [44], implying that high-intensity exercise
training might be more beneficial than moderate-intensity
training in reducing the risk of chronic cardiovascular and
Fig. 2 Participants’ individual V̇O2peak responses to HIIT in group 1 (top panel) and group 2 (bottom panel)
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metabolic diseases. This notion is supported by another
study that demonstrated that a combination of high-in-
tensity aerobic exercise, plus resistance exercise train-
ing, in addition to daily physical activity, is required to
achieve a significant anti-inflammatory effect in T2DM
patients [40].
Contrary to the present findings, Leggate and colleagues
[41] demonstrated significant reductions in circulating sIL-
6R, IL-6/sIL-6R complex, adiponectin and MCP-1 of
approximately 10%, 13%, 11% and 12%, respectively, within
an obese cohort. Given that the volume of HIIT used by
Leggate was 4 times the volume of that in the current study
it may be suggested that in order to reduce inflammatory
profile, a minimal volume of HIIT must be attained.
Glucose Metabolism
Inflammation has been independently implicated in the
development of insulin resistance and T2DM [6] and is
Fig. 3 Group 1 percentage change in body composition parameters pre and post 2 weeks of HIIT
Fig. 4 Group 2 percentage change in body composition parameters pre and post 2 weeks of HIIT
Kelly et al. BMC Obesity  (2017) 4:17 Page 6 of 12
characterised by abnormal cytokine production, increased
production of acute phase reactants as well as activation
of a network of inflammatory signalling pathways [7]. In-
sulin stimulates tyrosine phosphorylation of insulin recep-
tor signalling (IRS) proteins, which is a crucial event in
mediating insulin action and is the primary signalling de-
fect of systemic insulin resistance. Inflammatory media-
tors promote insulin resistance through inhibitory serine
phosphorylation of IRS-1. IRS-1 serine phosphorylation
disrupts insulin-receptor signalling through several dis-
tinct mechanisms, ultimately blocking insulin action [45].
Various studies have investigated the effects of 2 weeks
of SIT or HIIT training on glucose metabolism [18, 22,
24, 27, 41, 46]. To the best of the author’s knowledge
this study is the first to investigate HIIT together with
reduced frequency HIIT training within an overweight
and obese cohort.
In the present investigation there were no measurable
changes in fasting glucose or insulin following 2 weeks
of HIIT or reduced frequency HIIT. Our findings are in
agreement with previous work after 2 weeks of SIT
training [18, 22, 24]. Whyte and colleagues [24] failed to
Fig. 5 Participants’ individual basal fasted glucose responses to HIIT
in group 1 (top panel) and group 2 (bottom panel)
Table 2 Intra-assay coefficients of variance (CV) between duplicate samples for inflammatory protein analysis in plasma
Group 1 Group 2
Pre-Training Post-Training p Pre-Training Post-Training p
Range (Median) Range (Median) Mean
ΔChange
Sig. < 0.05 Range (Median) Range (Median) Mean ΔChange Sig. < 0.05
Adiponectin (μg.ml-1) 1.1–14.6 (2.3) 0.8–10.9 (1.7) −0.3 0.123 0.6–8.3 (2.2) 0.5–7.6 (1.9) −2.0 0.158
IL-10 (pg.ml-1) 0.5–0.7 (0.5) 0.5–0.7 (0.5) −0.03 0.304 0.4–0.8 (0.5) 0.5–1.0 (0.5) −0.05 0.337
TNF-α (pg.ml-1) 1.4–2.6 (2.3) 1.1–3.2 (2.2) −0.02 0.903 1.7–4.9 (2.5) 1.7–4.4 (2.5) −5.4 0.704
CRP (μg.ml-1) 0.1–5.7 (1.5) 0.1–3.8 (1.5) −0.3 0.358 0.2–4.0 (1.1) 0.1–3.6 (0.6) −0.4 0.067
IL-6 (pg.ml-1) 1.6–112.4 (3.5) 1.3–87.0 (3.7) −9.0 0.111 1.0–11.1 (2.8) 1.2–8.4 (2.6) −0.5 0.182
sIL-6R (ng.ml-1) 21.3–36.3 (24.8) 19.8–32.3 (27.9) 1.2 0.518 21.7–51.0 (25.1) 23.6–65.3 (30.7) 4.2 0.246
MCP-1 (pg.ml-1) 51.4–411.1 (157.3) 55.8–181.0 (148.2) −38.7 0.255 107.4–246.3 (143.5) 65.5−255.6 (141.3) 0.5 0.976
Inflammatory proteins in plasma for groups 1 and 2, pre and post 2 weeks of HIIT
Group 1 (N = 8); Group 2 (N = 10)
Fig. 6 Participants’ individual insulin resistance (Matsuda Index)
responses to HIIT in group 1 (top panel) and group 2 (bottom panel)
Kelly et al. BMC Obesity  (2017) 4:17 Page 7 of 12
demonstrate changes in fasting glucose concentrations
following 2 weeks (6 sessions) of SIT within an obese
cohort however did show a significant 25% reduction in
fasting plasma insulin concentrations. Similar adapta-
tions were demonstrated by Hood and colleagues [46]
following the same training intervention albeit in a sed-
entary population, defined as not having participated in
a regular exercise programme for at least 1 year before
the study. Leggate [41] showed no change in fasting glu-
cose, insulin, insulin sensitivity index or AUC response
to a 2 h OGTT after 2 weeks of HIIT.
We failed to demonstrate any change in area under
the 2 h OGTT curve following HIIT or reduced HIIT.
Contrary to our findings, 2 weeks of SIT [18, 24] and
HIIT [27] have been shown to be effective in reducing
area under the curve. Notably, Little et al [27] utilised a
protocol identical to that adopted in the current study
within a T2DM cohort. After 6 sessions of exercise, area
under the 24 h blood glucose curve was reduced from
11,066 ± 1703 to 9572 ± 995 mmol.l-1.day-1. Whyte and
colleagues [24] demonstrated similar findings, describing
a significant reduction of 15% in 2 h insulin AUC follow-
ing 2 weeks of SIT in an obese cohort.
With reference to insulin sensitivity indices, the
current study is one of few to profile changes following
2 weeks of HIIT. No changes in insulin sensitivity (as
measured via Matsuda index) were measured in either of
the 2 experimental groups. These data contrast that of
previous work which demonstrated significant improve-
ments in insulin sensitivity following 2 weeks of SIT
training [18, 22, 24]. Notably Hood and colleagues [46]
indicated that after 2 weeks of HIIT, insulin sensitivity as
measured by HOMA, increased significantly by 35% in a
group of sedentary adults.
Peak aerobic capacity
In the present study, groups 1 and 2 demonstrated no
change in V̇O2peak following training. These results are
Fig. 7 a Group 1 plasma glucose (a) and insulin (b) response to a 75 g OGTT pre and post 2 weeks of HIIT. (dashed line) represents pre-training.
(solid line) represents post training. b Group 2 plasma glucose (a) and insulin (b) response to a 75 g OGTT pre and post 2 weeks of HIIT. (dashed line)
represents pre-training. (solid line) represents post training
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consistent with previous findings [12, 14, 19]. Contrary
to our findings, other previous reports have revealed sig-
nificant improvements in V̇O2max [24, 41, 47, 48] follow-
ing 2 weeks of training. Talanian and colleagues [48]
demonstrated that following 6 HIIT sessions V̇O2peak
was increased in healthy women. Later Whyte [24] dem-
onstrated significant improvements in V̇O2max following
2 weeks of SIT within an obese population. The authors
attributed significant improvements to a relatively low
level of baseline fitness within their cohort. This is
unlikely given that baseline aerobic capacity neither posi-
tively nor negatively associates with gains in exercise train-
ing induced maximal aerobic power [49, 50].
The work of Billat and colleagues clearly elucidates
that improvements in V̇O2max correlate highly with total
time spent exercising at V̇O2max [51]. Data detailing time
spent at V̇O2max during sub-maximal HIIT interventions
is sparse making it difficult to relate training outcomes
to this training parameter. Data from 30 s Wingate
sprints demonstrates that trained individuals only spend
between 18 and 22 s working at ≥ 90% V̇O2max [52].
Typically this intensity was not achieved in the present
study until repetition number 7, despite only a 7% drop
in oxygen consumption by the end of 1 min recovery
periods. Of note, once achieving peak intensity at repeti-
tion 7, participants failed to increase this in subsequent
intervals. It is this short accumulative time spent at
V̇O2max, which makes it possibly not surprising that
previous SIT and particularly submaximal HIIT studies
such as ours, have failed to observe measurable changes
in maximal aerobic power after 2 weeks.
Clearly intensity of exercise is a critical consideration
when viewing responses to a training study. As per the
work of Billat and colleagues the greater the accumulative
time spent close to V̇O2max the greater the benefits that are
likely to be achieved in aerobic capacity. Previous work in
similar populations utilising the same intensity have dem-
onstrated significant improvements in V̇O2max ranging
from 8% to 35% [41, 53–56]. Non-surprisingly within these
studies there is a clear trend between level of improvement
and total training volume. Data is inconclusive as to
whether training at intensities above those utilised in the
current study lead to better outcomes in aerobic capacity.
A number of studies [16, 24, 57–60] in similar populations
to those in this work have demonstrated improvements
comparable to those at lower intensities [41, 53–56]. It
may be interesting to speculate therefore, that a thresh-
old for potential adaptation is reached at approximately
80% V̇O2max, with further improvements governed by
training volume. Laursen and colleagues [61] support
this view, suggesting that a greater volume of intense
exercise is required in order to effectively improve
V̇O2max. What is clear from the present study is that
the protocol utilised did not meet the hypothetical
duration or intensity pre-requisites required to improve
aerobic capacity.
Body Composition
The current study is the first to incorporate both
standard anthropometric measures and DEXA analysis
before and after 2 week HIIT intervention of these
volumes. Results indicated that no changes were de-
tected for either group 1 or 2 in total body mass,
waist or hip circumferences or waist:hip ratio. Fur-
thermore, no changes were detected in tissue fat (%),
regional fat (%), fat mass (g), lean mass (g) or bone
mineral content (BMC) (g).
Waist circumference is an independent predictor of
ectopic fat deposition and is one of the key screening
variables used to identify those with metabolic syndrome
[62]. To the best of our knowledge there have only been
2, 2 week SIT or HIIT interventions that note waist cir-
cumference changes [24, 41]. Both Whyte and Leggate
describe reductions in waist circumferences of 2.4 cm
and 1.4 cm respectively. These reductions in waist cir-
cumferences seem improbable after only 2 weeks espe-
cially without dietary restrictions; with average exercise
energy expenditures of 735 kJ for Wingate sprints [63],
2788 kJ for a typical 60 min exercise session utilised by
Leggate and colleagues and 1151 kJ for a typical session
used within the current study [64]. It may be that vari-
ability within the measurement accuracy of waist cir-
cumference played a role in divergent data between pre
and post intervention.
Our data are in agreement with previous work utilis-
ing longer HIIT periods lasting ~ 10 weeks [57, 58, 65].
Previous groups showed no changes in any anthropo-
metric measurements following HIIT and equally saw
no change in control groups performing continuous
moderate-intensity exercise. Data from studies ranging
between 3 and 6 months however show significant
changes in BMI, body mass, body fat (%) and waist or
hip circumferences [21, 53, 59, 66]. The equivalency of
anthropometric changes in those studies may be attrib-
utable to high accumulative exercise energy expend-
iture. Notwithstanding it may be hypothesised that
given an average energy expenditure of 1151 kJ per
HIIT session for group 1 in the present study, and as-
suming that 36,000 kJ equates to 1 kg of fat, an individ-
ual may stand to ‘burn’ ~ 2.3 kg of fat over a 6 month
period with group 2 likely to achieve ~ 50% of this.
With this in mind, data then becomes comparable to
that of previous longer-term HIIT interventions. These
data would suggest that HIIT interventions longer than
3 months in duration are required in order to see bene-
ficial changes in body composition, assuming no
change in dietary intake.
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Conclusion
Existing data suggests that SIT and HIIT training can be
effective in improving insulin sensitivity, body compos-
ition, V̇O2max [67], and inflammation [66]. The current
study demonstrates that not all short-term HIIT proto-
cols are effective in providing significant health benefits.
It remains unknown if a longer duration training period,
utilising identical exercise protocols would be sufficient
in improving cardio-metabolic health profile in the same
cohort and therefore warrants further investigation.
Given the ever increasing diversity of exercise prescrip-
tion, and indeed the urgency for low cost and scalable
preventative health interventions, it is now vital that
clinical practice optimises regimens for independent
health outcomes and equally ensures that exercise design
is specific to any given participant cohort.
We demonstrate that a protocol utilising 10 X 1 min
intervals at 90% HRpeak with 1 min recovery periods is
not sufficient in improving health markers within an
overweight and obese group over this time course. This
should be an active consideration for practitioners consid-
ering similar preventative interventions in this group.
Further work building upon this trial should aim to evalu-
ate participant groups whom demonstrate less favourable
baseline metabolic characteristics. The present cohort
demonstrated glucose, insulin and inflammatory values
within healthy range which may therefore be a plausible
reason for lack of findings in this trial.
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